PharmAthene Common Shares and Warrants to Resume Trading on the American Stock Exchange
08 8월 2007 - 4:32AM
PR Newswire (US)
ANNAPOLIS, Md., Aug. 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
(AMEX:HAQ), a biodefense company developing and commercializing
medical countermeasures against biological and chemical threats,
today announced that the Company's common stock and warrants will
resume trading today on the American Stock Exchange under the
original symbol "HAQ" as to the Company's common shares and
"HAQ.WS" as to its warrants. Trading is expected to resume at
approximately 2:45 p.m. today, August 7, 2007. Effective tomorrow,
trading will occur under the Company's new symbol "PIP" as to its
common shares and "PIP.WS" as to its warrants. PharmAthene intends
to conduct an investor conference call to address questions related
to the recent merger of Healthcare Acquisition Corp. and
PharmAthene. Further information about the conference call will be
provided shortly. Additional Information PHARMATHENE CLAIMS THE
PROTECTION OF THE SAFE HARBOR FOR "FORWARD-LOOKING STATEMENTS"
WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT
OF 1995. FORWARD-LOOKING STATEMENTS ARE STATEMENTS THAT ARE NOT
HISTORICAL FACTS. SUCH FORWARD-LOOKING STATEMENTS, BASED UPON THE
CURRENT BELIEFS AND EXPECTATIONS OF MANAGEMENT OF PHARMATHENE
REGARDING, AMONG OTHER THINGS, THE POTENTIAL DETERMINATIONS BY A
COURT OF CHANCERY IN DELAWARE AS TO THE VALIDITY OF THE APPROVAL OF
THE MERGER, WHICH CANNOT BE PREDICTED WITH CERTAINTY. NO ASSURANCES
CAN BE GIVEN THAT OTHER PARTIES WILL NOT OPPOSE CONFIRMATION OF
SUCH VALIDITY. About PharmAthene, Inc. PharmAthene was a
privately-held biodefense company, was formed in 2001 to meet the
critical needs of the United States by developing biodefense
products. PharmAthene is dedicated to the rapid development of
important and novel biotherapeutics to address biological pathogens
and chemicals that may be used as weapons of bioterror.
PharmAthene's lead programs include Valortim(TM) and Protexia(R).
For more information on PharmAthene, please visit its website at
http://www.pharmathene.com/. Following approval of the merger at
HAQ's Special Meeting of Stockholders held on Friday, August 3,
2007, the name of PharmAthene was changed to "PharmAthene US
Corporation." About Healthcare Acquisition Corp. Des Moines-based
Healthcare Acquisition Corp. was jointly formed by healthcare
investing pioneers, John Pappajohn and Derace L. Schaffer, M.D.
Healthcare Acquisition Corp. was a special purpose acquisition
company focused on the healthcare industry. The Company's shares
traded on the American Stock Exchange, under the symbol HAQ and its
warrants traded on the American Stock Exchange under the symbol
HAQW. Following HAQ's Special Meeting of Stockholders held on
Friday, August 3, 2007, the name of HAQ was changed to
"PharmAthene, Inc." DATASOURCE: PharmAthene, Inc. CONTACT: Stacey
Jurchison of PharmAthene, Inc., +1-410-269-2610, Web site:
http://www.pharmathene.com/
Copyright
Healthcare Acquisition (AMEX:HAQ)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Healthcare Acquisition (AMEX:HAQ)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Healthcare Acquisition Corp (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More Healthcare Acquisition Corp News Articles